News X Close Refine your results Search here results search-total-matching103search-total-matching Existing drugs could benefit patients with bone cancer, genetic study suggests | UCL Cancer Institute - UCL - London's Global University New drug trial effective in shrinking cervical cancer tumours | UCL Cancer Institute - UCL - London's Global University FOXFIRE combined analysis study results announced | UCL Cancer Institute - UCL - London's Global University Drug improves survival of patients with rare cancer by almost a quarter | UCL Cancer Institute - UCL - London's Global University Promising pre-clinical results for modified antibody targeting CD25 | UCL Cancer Institute - UCL - London's Global University International team receive $1.2 million boost for neuroendocrine cancer research | UCL Cancer Institute - UCL - London's Global University Tracking unstable chromosomes helps predict lung cancer’s return | UCL Cancer Institute - UCL - London's Global University New region in noncoding DNA linked to leukaemia | UCL Cancer Institute - UCL - London's Global University TRAIL discovery points to new target for cancer therapy | UCL Cancer Institute - UCL - London's Global University Combining statins with chemotherapy does not extend survival in lung cancer | UCL Cancer Institute - UCL - London's Global University 1234567891011 Please enable JavaScript to use this page or visit this page for a non javascript version.
X Close Refine your results Search here results search-total-matching103search-total-matching Existing drugs could benefit patients with bone cancer, genetic study suggests | UCL Cancer Institute - UCL - London's Global University New drug trial effective in shrinking cervical cancer tumours | UCL Cancer Institute - UCL - London's Global University FOXFIRE combined analysis study results announced | UCL Cancer Institute - UCL - London's Global University Drug improves survival of patients with rare cancer by almost a quarter | UCL Cancer Institute - UCL - London's Global University Promising pre-clinical results for modified antibody targeting CD25 | UCL Cancer Institute - UCL - London's Global University International team receive $1.2 million boost for neuroendocrine cancer research | UCL Cancer Institute - UCL - London's Global University Tracking unstable chromosomes helps predict lung cancer’s return | UCL Cancer Institute - UCL - London's Global University New region in noncoding DNA linked to leukaemia | UCL Cancer Institute - UCL - London's Global University TRAIL discovery points to new target for cancer therapy | UCL Cancer Institute - UCL - London's Global University Combining statins with chemotherapy does not extend survival in lung cancer | UCL Cancer Institute - UCL - London's Global University 1234567891011 Please enable JavaScript to use this page or visit this page for a non javascript version.
Close
